A bold new plan could finally cure type 1 diabetes
Researchers at the Medical University of South Carolina are developing a two-part therapy that pairs lab-made insulin-producing cells with custom-engineered immune cells to protect the grafts without chronic immunosuppression; the program received $1 million to advance a ready-to-use treatment for people with longstanding type 1 diabetes.
Why it matters$1 million funds Medical University of South Carolina's paired cell therapy for type 1 diabetes.
Entities Mentioned
Medical University of South Carolina